These findings indicate that (-)-DHMEQ suppressed mast cell migration via the inhibition of NF-κB-regulated MMP-2 expression.
tory cells, including mast cells, lymphocytes and eosinophils [4] . It has previously been shown that rat basophilic leukemia RBL-2H3 cells sensitized with antigen-specific IgE migrate toward the antigen, and this migration is directional [4] . Moreover, mast cell invasion is not only involved in inflammation but also in cancer malignancy [5] .
Activation of the FcεRI receptor in mast cells induces the IKK-NF-κB pathway [6] . NF-κB activation mediated by IgE/DNP induces the expression of inflammatory cytokines such as TNF-α and IL-6 in RBL-2H3 cells [7] . In cancer cells, NF-κB activation also induces cell migration and invasion by inducing matrix metalloproteinase (MMP)-9, urokinase-type plasminogen activator and ICAM-1 [8] . On the other hand, the relationship between NF-κB activation and the motility of mast cells is unknown.
Previously, we designed and synthesized a novel NF-κB inhibitor, (-)-dehydroxymethylepoxyquinomicin, called (-)-DHMEQ ( fig. 1 a) [9] . DHMEQ is synthesized as its racemic form, and after chiral separation the (-)-DHMEQ enantiomer is about 10 times stronger than the (+)-DHMEQ enantiomer [10] . (-)-DHMEQ inhibits the translocation of NF-κB protein to the nucleus [11] and DNA binding activity of NF-κB by covalently binding to specific cysteine residues of the protein [12] . (-)-DHMEQ showed various anti-inflammatory effects on animal models, including rheumatoid arthritis [13] and renal inflammation [14] .
In the present research, we found that the NF-κB inhibitor (-)-DHMEQ inhibited IgE-sensitized cell invasion in mast cell-like RBL-2H3 cells and mouse bone marrow-derived mast cells and revealed the inhibitory mechanism.
Materials and Methods
Materials (-)-DHMEQ was synthesized in our laboratory as previously described [10] . DNP-albumin conjugate, bovine, pan-MMP inhibitor GM6001 and the selective MMP-2 inhibitor cis-9-octadecenoyl-N-hydroxylamide (OA-Hy), were purchased from Calbiochem (Darmstadt, Germany). Monoclonal anti-dinitrophenyl antibody IgE SPE-7 and anti-MMP-2 antibody were purchased from Sigma (St. Louis, Mo., USA) and Daiichi Fine Chemical (Toyama, Japan), respectively.
Cell Culture
Rat basophilic leukemia RBL-2H3 cells were maintained in Dulbecco's modified Eagle's medium (Nissui Pharmaceutical Co. Ltd., Tokyo, Japan) supplemented with 10% (v/v) heat-inactivated FBS, 200 U/ml penicillin G, 200 mg/l kanamycin, 600 mg/l L -glutamine, and 2.25 g/l NaHCO 3 at 37 ° C in a humidified incubator with 5% CO 2 . Mouse bone marrow-derived mast cells (BMMCs) were generated from 6-week-old C57BL/6 mice according to the method described previously [15] . Briefly, bone marrow cells in alpha modification of Eagle's medium (α-MEM; Invitrogen, Carlsbad, Calif., USA) containing 10% FBS, 100 U/ml penicillin G, 100 μg/ml streptomycin, 1 m M sodium pyruvate, 0.1 m M nonessential amino acid, and 50 μ M 2-mercaptoethanol (Invitrogen) supplemented with 10 ng/ml mIL-3 (PeproTech, Rocky Hill, N.J., USA) were cultured at 37 ° C in a humidified atmosphere of 5% CO 2 . Nonadherent cells were transferred every week for up to 4 weeks into fresh culture medium. BMMCs were used when >95% of the cells were mast cells determined by flow cytometry for FcεRIα expression and by toluidine blue staining.
Cellular Invasion through Matrigel
Assays were performed using a 24-well Matrigel invasion chamber with a pore size of 8.0 μm (BD Biosciences, Bedford, MA) [16] or 24-well cell culture inserts with 8-μm pore size filters (BD Biosciences) coated with 100 μl of Matrigel (BD Biosciences) to form a thin continuous layer and allowed to solidify at 37 ° C for 1 h [17] . The lower compartment was filled with 500 μl of the serum-free medium, with or without the indicated concentration of DNP-BSA. RBL-2H3 cells (2.0 × 10 5 ) or BMMCs (1.0 × 10 6 ) were resuspended in 500 μl of the same medium and placed in the upper part of the Matrigel plate. The cells were incubated for 24 h and then fixed and stained. Cells on the upper surface of the filter were removed mechanically by wiping with a cotton swab and, under light microscopic observation, the invasive phenotypes were determined by counting the cells that had migrated to the lower side of the filter. Three randomly selected fields were counted from each well and experiments were repeated 3 times. Cell growth was measured with Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan) as previously described [18] .
Electrophoretic Mobility Shift Assay
An electrophoretic mobility shift assay for NF-κB binding to DNA was carried out as described [12] . The DNA probes used for NF-κB binding were the previously described double-stranded oligonucleotides [19] or NF-κB IRDye 700 oligonucleotides (LI-COR Biosciences, Lincoln, Nebr., USA) .
RNA Isolation and Semiquantitative RT-PCR Analysis
Total RNA was extracted from RBL-2H3 cells using TRIzol reagent (Invitrogen). Reverse transcription was carried out with the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, Calif., USA). The cDNA was used for PCR amplification with rTaq DNA polymerase (Takara Bio, Shiga, Japan). The sequences of the primers used for semiquantitative RT-PCR, the numbers of cycles and the annealing temperatures are shown in online supplementary table 1 (for all online suppl. material, see www.karger.com/doi/10.1159/000371419).
Real-Time PCR Array
Total RNA was extracted from RBL-2H3 cells using RNeasy mini (Qiagen, Hilden, Germany). Reverse transcription was carried out at 42 ° C for 15 min with the RT2 First Strand Kit (Qiagen). The cDNA was used for PCR amplification with RT2 SYBR Green ROX qPCR Master Mix (Qiagen). The cDNA was added to the qPCR Master Mix and the aliquot mixture across the Rat Cell Motility PCR Array (Qiagen). Hprt1 was used as a housekeeping gene. Data analysis was carried out by the comparative Ct method. 
Results

Inhibition of NF-κB and Migration by (-)-DHMEQ in RBL-2H3 Cells
IgE/DNP-BSA-induced NF-κB activation was inhibited by (-)-DHMEQ ( fig. 1 a) in rat mast cell-like RBL-2H3 cells at its nontoxic concentrations ( fig. 1 b) . It also inhibited NF-κB downstream genes such as TNF-α and IL-6 ( fig. 1 c) . Moreover, (-)-DHMEQ was found to inhibit the migration of IgE-sensitized RBL-2H3 cells toward the antigen in a Matrigel chamber assay without any toxicity ( fig. 1 d) . 
Inhibition of MMP-2 Expression by (-)-DHMEQ
We next searched for critical factors responsible for cell invasion that are regulated by NF-κB. Then, we searched for those specific genes using a real-time PCR array system arranged for cell motility. RBL-2H3 cells were treated with IgE/DNP with or without (-)-DHMEQ. We then compared the gene expression of (-)-DHMEQtreated and untreated cells. We evaluated 84 genes related to cell motility. Expressions of cell motility-related genes such as MMP-2, Pak4 and Akt1 were lowered by (-)-DHMEQ, as shown in table 1 . Among them, we focused on MMP-2 expression in RBL-2H3 cells and analyzed it by semiquantitative RT-PCR. (-)-DHMEQ inhibited IgE-DNP-induced MMP-2 expression in a dose-dependent manner, while it did not inhibit MMP-13 and MT1-MMP expression in RBL-2H3 cells ( fig. 2 a) . MMP-9 expression was not detected in RBL-2H3 cells, though it was detected in rat kidney NRK49F cells. Inhibition of MMP-2 expression by (-)-DHMEQ was also confirmed at the protein level ( fig. 2 b) . To study whether MMP-2 mRNA transcription is directly regulated by NF-κB, we employed a protein synthesis inhibitor, cycloheximide. Cycloheximide did not inhibit IgE/DNPinduced MMP-2 mRNA expression, indicating that MMP-2 expression was due to the binding of NF-κB to the MMP-2 promoter (online suppl. fig. 1 ).
Inhibition of Cellular Invasion by MMP Inhibitor GM6001
Next we studied whether MMP-2 is involved in RBL-2H3 invasion, and employed the MMP inhibitor GM6001, which is known to inhibit MMP-2 [20] . GM6001 inhibited IgE-sensitized cell invasion toward the antigen in RBL-2H3 cells, as shown in figure 3 a. Moreover, cotreatment with GM6001 and (-)-DHMEQ did not show additive inhibition compared with (-)-DHMEQ alone or GM6001 alone ( fig. 3 a) . In addition, the selective MMP-2 inhibitor OA-Hy also inhibited RBL-2H3 cell invasion, although this chemical is slightly toxic ( fig. 3 b) .
Inhibition of Cellular Invasion and MMP-2 Expression by (-)-DHMEQ in Primary Culture Mouse Mast Cells
We prepared a primary culture of mouse mast cells, as described in Methods. We then studied the effect of (-)-DHMEQ on NF-κB activity, MMP-2 expression and Matrigel invasion in these cells. (-)-DHMEQ inhib- RBL-2H3 cells were treated as described in Materials and Methods. The top 10 genes and names of the corresponding proteins downregulated by (-)-DHMEQ (10 μg/ml) are listed.
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Discussion
NF-κB plays a central role in allergic inflammation, since it promotes the transcription of Th2 cytokines such as IL-6. Treatment with NF-κB decoy oligodeoxynucleotides inhibits atopic dermatitis in the NC/Nga atopic mouse model, and this inhibition is accompanied by a significant decrease in the infiltration of mast cells into the dermis [21] . Moreover, ointment containing DHMEQ improves atopic dermatitis manifestation in mice, with an efficacy equivalent to that of tacrolimus or betamethasone [22] . DHMEQ inhibited mast cell accumulation in the inflammatory site in this experiment [22] . Thus, it is likely to inhibit mast cell activity by inhibition of its invasion in animal experiments ( fig. 1 d) .
We identified MMP-2 as a new target gene of NF-κB in rat basophilic leukemia RBL-2H3 cells. It is reported that the NF-κB complex is composed of a heterodimer of p65 and p50 when activated by IgE/DNP-BSA in RBL-2H3 cells [19] . We observed that the band of NF-κB was weakened by treatment with either anti-p65 antibody or anti-RelB antibody in IgE/DNP-BSA-treated RBL-2H3 cells in the electrophoretic mobility shift assay (data not shown). Therefore, it is likely that both canonical and noncanonical NF-κB activation pathways would be activated in RBL-2H3 cells.
Our PCR array data demonstrated that (-)-DHMEQ decreased the expression of several cell motility-related genes in RBL-2H3 cells ( table 1 ) . We focused on MMP-2 because the expression of MMP-2 has been linked with tumor invasion, angiogenesis and metastasis [23] , and MMPs appear to be involved in allergic inflammation [24] . MMP-2 was detected in RBL-2H3 cells [25] , but its role in RBL-2H3 cells remains to be revealed.
We investigated the regulation of MMP-2 mRNA transcription by luciferase promoter analysis. The rat MMP-2 promoter has an NF-κB consensus binding site 
89
(-823 to -813 bp). However, the MMP-2 promoter region from 1,000 bp upstream to 83 bp downstream did not affect promoter activity in the deletion analysis. Thus, the upregulation of MMP-2 by IgE/DNP would be mediated by the complex of NF-κB and other transcription factors such as Sp-1 and C/EBPβ that bind to another MMP-2 promoter site. Thus, mast cell trafficking should also be regulated by IgE-independent triggers with various cytokines. Involvement of NF-κB in these IgE-independent mechanisms remains to be studied.
In conclusion, our findings indicate that (-)-DHMEQ suppressed mast cell migration via the inhibition of NF-κB-regulated MMP-2 expression. (-)-DHMEQ may be a candidate as an antiallergy agent inhibiting mast cell accumulation. 
